SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism

Abstract Localized in the mitochondria, SIRT4 is a nicotinamide adenine dinucleotide (NAD +) -dependent adenosine diphosphate (ADP) -ribosyltransferase and is one of the least characterized members of the sirtuin family. Although it is well known that it shows deacetylase activity for energy metabol...

Full description

Bibliographic Details
Main Authors: Guohao Cai, Zhuhui Ge, Yunqiu Xu, Liangliang Cai, Pingliang Sun, Guoyu Huang
Format: Article
Language:English
Published: Nature Portfolio 2022-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-16610-8
_version_ 1818199307311906816
author Guohao Cai
Zhuhui Ge
Yunqiu Xu
Liangliang Cai
Pingliang Sun
Guoyu Huang
author_facet Guohao Cai
Zhuhui Ge
Yunqiu Xu
Liangliang Cai
Pingliang Sun
Guoyu Huang
author_sort Guohao Cai
collection DOAJ
description Abstract Localized in the mitochondria, SIRT4 is a nicotinamide adenine dinucleotide (NAD +) -dependent adenosine diphosphate (ADP) -ribosyltransferase and is one of the least characterized members of the sirtuin family. Although it is well known that it shows deacetylase activity for energy metabolism, little is understood about its function in tumorigenesis. Recent research suggests that SIRT4 may work as both a tumor suppressor gene and an oncogene. However, the clinical significance of SIRT4 in prostate cancer remains unknown. In this study, we evaluated SIRT4 protein levels in cancerous prostate tissue and corresponding non-tumor prostate tissue via immunohistochemical staining on a tissue microarray including tissues from 89 prostate cancer patients. The association between SIRT4 expression and Gleason score was also determined. Further, shSIRT4 or stable prostate cancer cell lines (22RV1) overexpressing SIRT4 were constructed via lentiviral infection. Using Cell-Counting Kit-8 (CCK-8) assay, wound healing assay, migration, and invasion and apoptosis assays, the effects of SIRT4 on the migration, invasion ability, and proliferation of prostate cancer cells were investigated. We also determined the effect of SIRT4 on glutamine metabolism in 22RV1 cells. We found the protein levels of SIRT4 in prostate cancer tissues were significantly lower than those in their non-neoplastic tissue counterparts (P < 0.01); a lower SIRT4 level was also significantly associated with a higher Gleason score (P < 0.01). SIRT4 suppressed the migration, invasion capabilities, and proliferation of prostate cancer cells and induced cellular apoptosis. Furthermore, the invasion and migration of 22RV1 cells were mechanistically inhibited by SIRT4 via glutamine metabolism inhibition. In conclusion, the present study’s findings showed that SIRT4 protein levels are significantly associated with the Gleason score in patients with prostate cancer, and SIRT4 exerts a tumor-suppressive effect on prostate cancer cells by inhibiting glutamine metabolism. Thus, SIRT4 may serve as a potential novel therapeutic target for prostate cancer.
first_indexed 2024-12-12T02:19:41Z
format Article
id doaj.art-d6df71cd74034ad787e01b1f5c5a51d1
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-12T02:19:41Z
publishDate 2022-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-d6df71cd74034ad787e01b1f5c5a51d12022-12-22T00:41:42ZengNature PortfolioScientific Reports2045-23222022-07-0112111210.1038/s41598-022-16610-8SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolismGuohao Cai0Zhuhui Ge1Yunqiu Xu2Liangliang Cai3Pingliang Sun4Guoyu Huang5Department of Anorectal Surgery, Hainan General HospitalDepartment of Pediatrics, First Hospital of Ninghai CountyDepartment of Cardio-Thoracic Surgery, Rui’an People’s HospitalDepartment of Anorectal Surgery, The First Affiliated Hospital, Guangxi University of Traditional Chinese MedicineDepartment of Anorectal Surgery, The First Affiliated Hospital, Guangxi University of Traditional Chinese MedicineDepartment of Anorectal Surgery, Hainan General HospitalAbstract Localized in the mitochondria, SIRT4 is a nicotinamide adenine dinucleotide (NAD +) -dependent adenosine diphosphate (ADP) -ribosyltransferase and is one of the least characterized members of the sirtuin family. Although it is well known that it shows deacetylase activity for energy metabolism, little is understood about its function in tumorigenesis. Recent research suggests that SIRT4 may work as both a tumor suppressor gene and an oncogene. However, the clinical significance of SIRT4 in prostate cancer remains unknown. In this study, we evaluated SIRT4 protein levels in cancerous prostate tissue and corresponding non-tumor prostate tissue via immunohistochemical staining on a tissue microarray including tissues from 89 prostate cancer patients. The association between SIRT4 expression and Gleason score was also determined. Further, shSIRT4 or stable prostate cancer cell lines (22RV1) overexpressing SIRT4 were constructed via lentiviral infection. Using Cell-Counting Kit-8 (CCK-8) assay, wound healing assay, migration, and invasion and apoptosis assays, the effects of SIRT4 on the migration, invasion ability, and proliferation of prostate cancer cells were investigated. We also determined the effect of SIRT4 on glutamine metabolism in 22RV1 cells. We found the protein levels of SIRT4 in prostate cancer tissues were significantly lower than those in their non-neoplastic tissue counterparts (P < 0.01); a lower SIRT4 level was also significantly associated with a higher Gleason score (P < 0.01). SIRT4 suppressed the migration, invasion capabilities, and proliferation of prostate cancer cells and induced cellular apoptosis. Furthermore, the invasion and migration of 22RV1 cells were mechanistically inhibited by SIRT4 via glutamine metabolism inhibition. In conclusion, the present study’s findings showed that SIRT4 protein levels are significantly associated with the Gleason score in patients with prostate cancer, and SIRT4 exerts a tumor-suppressive effect on prostate cancer cells by inhibiting glutamine metabolism. Thus, SIRT4 may serve as a potential novel therapeutic target for prostate cancer.https://doi.org/10.1038/s41598-022-16610-8
spellingShingle Guohao Cai
Zhuhui Ge
Yunqiu Xu
Liangliang Cai
Pingliang Sun
Guoyu Huang
SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism
Scientific Reports
title SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism
title_full SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism
title_fullStr SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism
title_full_unstemmed SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism
title_short SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism
title_sort sirt4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism
url https://doi.org/10.1038/s41598-022-16610-8
work_keys_str_mv AT guohaocai sirt4functionsasatumorsuppressorduringprostatecancerbyinducingapoptosisandinhibitingglutaminemetabolism
AT zhuhuige sirt4functionsasatumorsuppressorduringprostatecancerbyinducingapoptosisandinhibitingglutaminemetabolism
AT yunqiuxu sirt4functionsasatumorsuppressorduringprostatecancerbyinducingapoptosisandinhibitingglutaminemetabolism
AT liangliangcai sirt4functionsasatumorsuppressorduringprostatecancerbyinducingapoptosisandinhibitingglutaminemetabolism
AT pingliangsun sirt4functionsasatumorsuppressorduringprostatecancerbyinducingapoptosisandinhibitingglutaminemetabolism
AT guoyuhuang sirt4functionsasatumorsuppressorduringprostatecancerbyinducingapoptosisandinhibitingglutaminemetabolism